FDBusiness.com

Gumlink Takes Stake in Canadian Probiotic and Nutraceutical Gum Manufacturer

 Breaking News
  • Heineken Delivers Strong Top-line Growth in 2019 Global brewer Heineken achieved 5.6% organic growth in net revenue (beia) to €23.894 billion for 2019 and operating profit grew 3.9% organically to €4.020 billion. However, the operating profit margin...
  • Molson Coors Partners With e.fundamentals to Help Drive UK Online Sales Molson Coors, one of the world’s largest brewers, has partnered with ecommerce analytics provider e.fundamentals to help drive sales of its beers through retailers’ websites in the UK. E.fundamentals’ service...
  • Manor Farm Wins IFSA Best Sustainable Food Product Award 2020 Irish chicken producer Manor Farm has won the IFSA (Irish Foodservice Suppliers Alliance) Best Sustainable Food Product Award 2020. Manor Farm, received the award for the company’s ‘Farmers to Market’...
  • Heineken Announces CEO Succession Jean-François van Boxmeer (pictured left), Chairman and CEO of Heineken, is to step down following his successful 15 year leadership of the company. He will be succeeded by Dolf van...
  • DMK Group Aims to Optimise Ice Cream Production DMK Group, Germany’s largest dairy co-operative, intends to streamline the production network in its ice cream business unit. This involves selling its Waldfeucht-Haaren production site in North Rhine-Westphalia. Schwarz Produktion,...

Gumlink Takes Stake in Canadian Probiotic and Nutraceutical Gum Manufacturer

Gumlink Takes Stake in Canadian Probiotic and Nutraceutical Gum Manufacturer
April 29
10:26 2011

Gumlink of Denmark has strengthened its leading position in the global nutraceutical chewing gum market by acquiring a 50% stake in Canada-based Tab Labs. Chewing gum is an ideal delivery system for nutraceutical products.

Like Gumlink, Tab Labs produces gum for the B2B marker and has recently shifted its focus towards the increasingly attractive functional and nutraceutical market. Tab Labs has especially concentrated on upgrading its facilities to accommodate extremely sensitive active ingredients such as probiotics.

Gumlink is the world’s leading B2B developer and manufacturer of chewing gum. It has accumulated vast expertise and experience in the pharmaceutical industry through sister company Fertin Pharma. This allows Gumlink to create nutraceutical concepts.

Gumlink will strengthen the new joint venture by contributing its nutraceutical chewing gum capabilities. The joint venture is among the first initiatives in Gumlink’s nutraceutical strategy for the future, launched in January 2011, involving strategic collaborations with various industry partners.

“This move makes perfect sense for us, as it will provide us with a nutraceutical manufacturing and distribution platform in North America and provides access to novel technologies that when combined with our own proprietary gum technologies will enable us to offer the most potent nutraceutical chewing gum assortment,” says Soren Birn, chief executive of Gumlink. “Furthermore, Gumlink is now following our strategic pathway to maintain and further build our position as the world’s leading nutraceutical gum developer and manufacturer.”

About Author

colin

colin

Related Articles

Food & Drink Business Conference & Exhibition 2016

Upcoming Events

[eventlist]

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements